Navigation Links
Confronting the challenge of antimicrobial resistance
Date:3/10/2008

Drug resistance is making many diseases increasingly difficult--and sometimes impossible--to treat, according to Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Extensively drug-resistant tuberculosis and invasive methicillin-resistant Staphylococcus aureus (MRSA) infections are just two recent examples of this problem that pose serious threats to domestic and global health, he adds. In a new report in the Journal of Infectious Diseases, now available online, Dr. Fauci outlines NIAIDs commitment to addressing this urgent public health issue.

The innate ability of microbes to evade containment and destruction by drugs through rapid reproduction and genetic mutation is exacerbated by the overuse and misuse of existing antimicrobial drugs, Dr. Fauci and his coauthors note. Other factors contributing to the upswing in drug resistance include a dearth of rapid diagnostic tests that would allow physicians to better gauge whether a given infection is drug-susceptible or drug-resistant, and a paucity of clinical trial data to guide therapeutic strategies.

NIAID is meeting the complex challenge of antimicrobial resistance through a multifaceted research approach that includes partnerships with other federal agencies, academia, industry and non-governmental organizations, the authors report. In fiscal year 2007, NIAID invested more than $800 million to support basic and translational research on antimicrobials, more than $200 million of which was devoted to understanding the causes, consequences and treatments of antimicrobial drug resistance.

Basic research projects under way at NIAID or in NIAID-supported labs across the country include the following:

  • Investigations of mechanisms of resistance and how these traits are acquired and passed on by microbes
  • Research on factors that contribute to the virulence of pa
    '/>"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. ADA Challenges Marylanders to Step Out to Fight Diabetes Epidemic
2. LifeQuest Announces End of Immunity Health Challenge Contest
3. Braun Challenges Business School Talent To Create A Buzz
4. Medifast Announces Winners of Mother-Daughter Challenge
5. The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival
6. Genetics Hold Promise, Challenges for Cancer Care
7. Actavis Confirms its Patent Challenge of Kings Avinza(R)
8. Childhood Obesity Epidemic a Long-Term Challenge
9. Planning for 2020: increasing elderly population poses huge challenges in cancer care
10. Barr Confirms Patent Challenge of UROXATRAL(R)
11. The Challenge: Make It A Million (Pounds Lost That Is)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... popular MTV programs about teenage pregnancy -- "16 and ... debate. Critics said the shows glamorized teenage pregnancy, while ... by an Indiana University professor suggests they,re both right. ... Sexuality & Culture, focused on female students ... among this demographic. , When the programs were under ...
(Date:5/22/2012)... microfluidic chip to test for latent tuberculosis. They hope ... than current testing for the disease. , "Our assay ... said Ying Liu, a research specialist working with Professor ... Engineering. , The team has already conducted testing of ... States. , About one-third of the world,s population is ...
(Date:5/22/2012)... Salamon HealthDay Reporter , , MONDAY, May ... move sure to unleash heated debate, a prominent ... of all ages no longer be screened for ... blood test. The U.S. Preventive Services Task ... prevention and evidence-based medicine, said PSA screening results ...
(Date:5/22/2012)... May 22 (HealthDay News) -- New Mexico has the ... while New Jersey has the lowest rate, according to ... 98 per 100,000 people, while New Jersey,s is about ... deaths is about 58 per 100,000, according to the ... the Robert Wood Johnson Foundation. Injuries that result ...
(Date:5/22/2012)... The national gastroenterology societies have issued a new ... The Multisociety Sedation Curriculum for Gastrointestinal Endoscopy ... complete and programmatic approach to the training of ... Gastroenterology , American Journal of Gastroenterology ... and in Gastroenterology Nursing . , ...
Breaking Medicine News(10 mins):Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 2Health News:Viewers' family background affects how they react to MTV shows 16 and Pregnant, Teen Mom 3Health News:New TB test promises to be cheap and fast 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3Health News:Injury-Linked Deaths Vary Widely Among States 2Health News:Gastroenterology Societies issue sedation curriculum for gastrointestinal endoscopy 2
... Inc.,(Nasdaq: IDMI ) today announced the presentation of ... patients,with lung metastases as a result of the progression ... typically affects children and young,adults. The data show that ... exhibited signs of disease control. "These results are ...
... PRGO ; TASE) announced today that Dexcel ... OTC 20mg Omeprazole delayed,release tablet, has settled its ... involving three Orange Book patents (,380,230 and ,505) ... of the,agreement have not been disclosed, the amicable ...
... Diabetes Month, HARRISBURG, Pa., Nov. 1 To ... Dr. Calvin Johnson today urged,Pennsylvanians to adopt healthy habits ... Diabetes is a chronic disease that affects an ... Pennsylvania., "Diabetes is a serious, public health concern ...
... InfoLogix, Inc. (Nasdaq:,IFLG), a leading technology provider of ... will release its financial results,for the Third Quarter ... Following the press release, President and Chief Executive ... will host a conference,call with the financial community ...
... IRVINE, Calif., Nov. 1 Masimo, the inventor,of ... pulse,oximetry, announced the completion of CHN,s system-wide implementation ... history of superior,Masimo SET performance in other areas ... SET pulse oximetry technology to virtually every site ...
... Thousands of public,health professionals will meet in Washington, ... the nation,s most pressing public health issues at ... The five-day meeting of more than 1,000 ... to draw around 14,000,public health researchers, practitioners and ...
Other Medicine News:Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 2Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 3Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 4Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 5Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 6Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 7Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 2Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 3Health News:Health Secretary Promotes Awareness of Diabetes, Urges Healthy Habits 2Health News:InfoLogix to Report Third Quarter and Nine Month Financial Results on November 8, 2007 2Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:14,000 Public Health Experts to Convene at American Public Health Association Annual Meeting in Washington, D.C. 2Health News:14,000 Public Health Experts to Convene at American Public Health Association Annual Meeting in Washington, D.C. 3
(Date:5/22/2012)... BOONTON, N.J., May 22, 2012  Unigene ... the design, delivery, manufacture and development of peptide-based ... preclinical studies in rats and dogs for its ... UGP281, a potent anorexigenic peptide selectively targeting the ... the treatment of morbid obesity.  In multiple-dose pharmacology ...
(Date:5/22/2012)... --  Valeritas , the maker of V-Go™ Disposable ... for the delivery of insulin designed especially for ... dLife to support its state-of-the-art patient engagement ... for people living with diabetes , and ... lifestyle management and support program designed to increase ...
(Date:5/22/2012)...   USANA Health Sciences , Inc. (NYSE: ... announced the promotion of Dr. John Cuomo to executive ... Dixon to executive director of new product and technological ... Mark Levy, a Ph.D. in human nutrition, and John ... professor at the University of Utah, have joined USANA,s ...
Breaking Medicine Technology:Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 2Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 3Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 5Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 2Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 3Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 4USANA Health Sciences Expands Award-Winning Research and Development Team 2USANA Health Sciences Expands Award-Winning Research and Development Team 3New microscopic life aboard the RMS Titanic 16752 1New microscopic life aboard the RMS Titanic 16752 2Low dose aspirin reduces death rates from range of cancers by between 20 and 30 percent 77629 1Low dose aspirin reduces death rates from range of cancers by between 20 and 30 percent 77629 2Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely 18071 1Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely 18071 2
... make retina, spinal cord and other central,nervous system ... Scientists at the,Schepens Eye Research Institute, an affiliate ... for successfully,transplanting tissue into the adult central nervous ... MMP-2 (which is induced by,stem cells) has the ...
... 2007 - A new study published,in the ... Neurology indicates,that a treatment from Medtronic, Inc. ... improves their quality of life and is,cost-effective ... of this Medtronic-sponsored study should,expand access to ...
Other Medicine Technology:Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 2Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 3Study Supports Cost-Effectiveness of Medtronic's Spasticity,Treatment for Children with Cerebral Palsy 4
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Testing for Strabismus (ocular misalignment) just became easier. By simply placing the StrabismoScope over the patient's eye, the examiner is able to observe the occluded eye directly, but the patien...
The Welch Allyn 125 BIO is designed to achieve precise binocular viewing and stereopsis easier than ever before. Its observation paths can be adjusted from 48 mm to 74 mm to handle the widest and nar...
Medicine Products: